• Lorcaserin and Phentermine Combo for Weight Management

    by Scott Isaacs, MD
    on May 12th, 2018

In the May 2017 issue of Obesity, Steven Smith, M.D. and coauthors performed a pilot study in 235 patients to assess the short-term tolerability of lorcaserin 10 mg twice daily monotherapy or when combined with phentermine 15 mg once daily or twice daily. Patients were assessed for weight loss over a 12 week period as well as potentially serotonergic adverse events (dry mouth, headache, dizziness, fatigue, insomnia, nausea, diarrhea, vomiting and anxiety). 37.2% of lorcaserin monotherapy group, 42.3% of the lorcaserin phentermine once daily group and 40.5% of the lorcaserin phentermine twice daily group reported potentially serotonergic adverse events. Headache and dry mouth were the most common adverse events. Adverse events leading to discontinuation were approximately double in the lorcaserin twice daily phentermine group compared to the lorcaserin monotherapy group. None of the potentially serotonergic adverse events were reported as serious and serotonin syndrome did not occur in any of the subjects. Mean weight loss was 3.3% in the lorcaserin monotherapy group, 6.7% in the lorcaserin phentermine once daily group and 7.2% in the lorcaserin phentermine twice daily group. A reduction of >5% of initial body weight was achieved in 28.2% of lorcaserin monotherapy subjects compared to 59.0% in lorcaserin phentermine once daily subjects and 70.9% in lorcaserin phentermine twice daily subjects.

This study evaluated combination pharmacotherapy with lorcaserin and phentermine which have distinct yet complimentary mechanisms of action. By targeting different signaling pathways, combination therapy has the potential to give better outcomes by overcoming adaptive mechanisms that can impede weight loss, thus improving efficacy. This study showed that the combination enhanced short-term weight loss but did not increase the incidence of potentially serotonergic adverse events. However, lorcaserin with twice daily phentermine did increase discontinuations compared to lorcaserin monotherapy and lorcaserin with once daily phentermine.

Author Scott Isaacs, MD Endocrinologist and Weight Loss Specialist

You Might Also Enjoy...

Do you have a fatty liver?

Fatty liver disease is the most common type of chronic liver disease and the number 2 cause for needing a liver transplant. It’s caused by a buildup of fat in the liver and can lead to cirrhosis or liver cancer.

Why Meal Replacements Work

According to the Journal of American Dietetic Association, “meal replacements were given the highest rating for weight loss and weight maintenance for people who have difficulty with self-selection and/or portion control”.

The 5 Key Components of Setting SMART Goals

When you set out to make any sort of change, no matter what it may be, setting a goal to work towards, or many small goals to break up the long road ahead, gives you a way to measure success.

How to Make Healthy Eating Easier

Wouldn’t it be great if the day you started a diet, you stopped craving any other foods? The reality, however, is that we all have food temptations that ride right alongside our best intentions for weight loss.

If It's Not My Thyroid Then What Is It?

Fatigue, weight gain, mood swings, poor concentration, memory issues, sweating, heart palpitations – your internet search says these are all symptoms of thyroid disease…but what happens when thyroid blood tests are actually normal?

How to Stay Motivated through the Tough Times

Sometimes, you’re on a roll with your diet and exercise/weight loss, but other times… not so much. How do you stay motivated at times like that? How do you stay committed? How do you maintain a sense of control when you don’t see the weight loss you were h

Location
Atlanta Endocrine Associates
775 Johnson Ferry Road NE
Atlanta, GA 30342
Phone: 404-531-0350
Office Hours

Get in touch

404-531-0350